The level of galectin-3 in the blood serum of patients with chronic hepatitis C

The level of galectin-3 in the blood serum of patients with chronic hepatitis C

Aim. to assess galectin-3 level in the serum of HCV patients according to the biochemical activity of hepatitis, liver fibrosis, in view of insulin resistance and overweight.Materials and methods: The content of serum galectin-3 was detected in 78 patients with chronic hepatitis C in age from 20 to...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Kovalevа, N. S. Zhevnerova, T. V. Antonova
Format:	Article
Language:	Russian
Published:	Journal Infectology 2016-07-01
Series:	Журнал инфектологии
Subjects:	chronic hepatitis c galectin-3 liver fibrosis insulin resistance metabolic syndrome
Online Access:	https://journal.niidi.ru/jofin/article/view/484
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lipid and carbohydrate metabolism disturbances in children with chronic hepatitis C
by: A. O. Nikiforova, et al.
Published: (2024-09-01)

Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)

Adiponectin level and severity of liver fibrosis in patients chronic hepatitis C with metabolic syndrome
by: A. F. Novikova, et al.
Published: (2018-07-01)

Comorbidity and multimorbidity in patients with chronic hepatitis C
by: Ya. E. Saranskaya, et al.
Published: (2022-10-01)

Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
by: I. A. Narkevich, et al.
Published: (2024-02-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

GALECTIN-3 LEVEL IN pATIENTS WITH mETAbOLIC SYNDROmE AND CORONARY HEART DISEASE
by: O. М. Drapkina, et al.
Published: (2017-03-01)

Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01)

Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)

Non-invasive diagnosis of fibrosis in patients with CHC and obesity
by: K. V. Zhdanov, et al.
Published: (2020-03-01)

FIB-4 and APRI scores for predicting severe fibrosis in chronic hepatitis C - a developing country's perspective in DAA era
by: Uros Karic, et al.
Published: (2018-03-01)

Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Galectin-3: role in the formation of various hemodynamic phenotypes of heart failure and interaction with some neurohumoral factors
by: A. K. Kurbonov, et al.
Published: (2020-08-01)

ACTUAL PRINCIPLES OF THERAPY CHRONIC HEPATITIS OF VARIOUS ETIOLOGIES
by: I. V. Semenova, et al.
Published: (2015-12-01)

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance
by: T. V. Antonova, et al.
Published: (2014-09-01)

THE ROLE OF CYTOKINE NETWORK IN HEPATOCELLULAR DAMAGE CAUSED BY СHRONIC HEPATITIS C
by: L. Ph. Skljar
Published: (2014-07-01)

CHEMOKINES AND THEIR RECEPTORS EXPRESSION IN BLOOD AND LIVER TISSUE IN CHRONIC HEPATITIS C
by: K. V. Zhdanov, et al.
Published: (2014-07-01)

Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C
by: I. A. Karabak, et al.
Published: (2020-06-01)

Chlorogenic acid attenuates cardiac hypertrophy and fibrosis by downregulating galectin 3
by: Seong Hoon Kim, et al.
Published: (2025-07-01)

Iron metabolism in chronic hepatitis C patients on antiviral treatment
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Phenotypic profile of blood monocytes and tumor-associated macrophages in relation to the expression of galectins 1 and 3 in colorectal cancer
by: A. V. Kurnosenko, et al.
Published: (2025-01-01)

s MadCAM-1 as an immunological marker in the «gut liver axis» at patients with chronic hepatitis C and excess body weight
by: K. V. Zhdanov, et al.
Published: (2019-05-01)

Diastolic dysfunction of myocardium and change of <i>Q–T</i> interval at chronic hepatitis C
by: A. A. Konysheva, et al.
Published: (2012-11-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

Сomparative morphological characteristics of activity score and fibrosis stage in chronic viral hepatitis C
by: I. L. Purlik, et al.
Published: (2010-10-01)

ASSOCIATIONS OF INTERFERON GENE POLYMORPHISMS OAS-1, OAS-3, PKR WITH CHRONIC VIRAL HEPATITIS C
by: V. A. Bychkov, et al.
Published: (2014-07-01)

IMPLICATION OF SERUM IL-17 LEVELS IN CHRONIC HEPATITIS B PATIENTS
by: Bülent Çakal, et al.
Published: (2021-01-01)

IMPACT OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C ON CYTOKINE SYNTHESIS AND HEPATIC FIBROSING PROCESSES
by: V. V. Shchekotov, et al.
Published: (2015-08-01)

The role of galectin-1 and galectin-3 in the mechanisms of T-cell immune response dysregulation in colon cancer
by: V. S. Poletika, et al.
Published: (2020-10-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Clinical, laboratory and coagulation system of blood feachers in patients with viral liver cirrhoses associated with virus hepatitis B, C and D
by: S. A. Bogushevich, et al.
Published: (2009-08-01)

The dynamic of psycho-emotional condition in patients with chronic HCV infection (F1-F3) treated with bicyclol
by: K. V. Kozlov, et al.
Published: (2025-03-01)

Lipid spectrum in liver cells and peripheral blood lymphocytes at children with chronic hepatitis B
by: V. G. Bulygin
Published: (2011-05-01)

GALECTIN-1 AND ITS ROLE IN DEVELOPMENT OF INNATE AND ADAPTIVE IMMUNITY
by: V. D. Yakushina, et al.
Published: (2014-07-01)